Lung health is getting more attention than ever in this COVID time and consumers’ interest and knowledge of lung health are at their highest. This webinar deep dives into lung health concerns beyond seasonal colds and flu. It will discuss the harder issues of lung inflammation and pulmonary scarring (observed in COPD and patients recovered from COVID-19) as well as an innovative BerriQi® formulation.
Chaired by Nutraingredients Asia Editor-in-Chief, Gary Scattergood, we are anticipating a vigorous and lively discussion.
• Preclinical findings on BerriQi®
• BerriQi® reverses the irreversible scar tissue
• A sarcoidosis patent’s experience
• Upcoming clinical
• Formulating with BerriQi®
Product Champion for BerriQi and Feiolix
Product Champion for Actazin and Livaux
Content provided by Anagenix
BerriQi® (proprietary blend of boysenberry and apple) has been formulated as a convenient daily dose of natural fruit bioactives that have been shown to support lung health. It is a delicious liquid supplement made from New Zealand boysenberries and apples,...